426 related articles for article (PubMed ID: 20805224)
1. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases.
Nonaka T; Watanabe ST; Iwatsubo T; Hasegawa M
J Biol Chem; 2010 Nov; 285(45):34885-98. PubMed ID: 20805224
[TBL] [Abstract][Full Text] [Related]
2. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.
Waxman EA; Giasson BI
J Neurosci; 2011 May; 31(21):7604-18. PubMed ID: 21613474
[TBL] [Abstract][Full Text] [Related]
3. alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress.
Riedel M; Goldbaum O; Richter-Landsberg C
J Mol Neurosci; 2009 Sep; 39(1-2):226-34. PubMed ID: 19266322
[TBL] [Abstract][Full Text] [Related]
4. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
Goedert M
Curr Opin Genet Dev; 2001 Jun; 11(3):343-51. PubMed ID: 11377973
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly.
Oikawa T; Nonaka T; Terada M; Tamaoka A; Hisanaga S; Hasegawa M
J Biol Chem; 2016 Jul; 291(29):15046-56. PubMed ID: 27226637
[TBL] [Abstract][Full Text] [Related]
6. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM; Giasson BI; Trojanowski JQ
Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
[TBL] [Abstract][Full Text] [Related]
7. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.
Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735
[TBL] [Abstract][Full Text] [Related]
8. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
9. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
Emmer KL; Waxman EA; Covy JP; Giasson BI
J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases.
Nonaka T; Masuda-Suzukake M; Hasegawa M
Neuropathology; 2018 Feb; 38(1):64-71. PubMed ID: 28948653
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration.
Abdelmotilib H; Maltbie T; Delic V; Liu Z; Hu X; Fraser KB; Moehle MS; Stoyka L; Anabtawi N; Krendelchtchikova V; Volpicelli-Daley LA; West A
Neurobiol Dis; 2017 Sep; 105():84-98. PubMed ID: 28576704
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells.
Kondo K; Obitsu S; Teshima R
Biol Pharm Bull; 2011; 34(7):1078-83. PubMed ID: 21720016
[TBL] [Abstract][Full Text] [Related]
13. A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation.
Waxman EA; Giasson BI
J Neurochem; 2010 Apr; 113(2):374-88. PubMed ID: 20132485
[TBL] [Abstract][Full Text] [Related]
14. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
Goedert M; Masuda-Suzukake M; Falcon B
Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
[TBL] [Abstract][Full Text] [Related]
15. The propagation of prion-like protein inclusions in neurodegenerative diseases.
Goedert M; Clavaguera F; Tolnay M
Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
17. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
[TBL] [Abstract][Full Text] [Related]
18. Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration.
Yeboah F; Kim TE; Bill A; Dettmer U
Neurobiol Dis; 2019 Dec; 132():104543. PubMed ID: 31351173
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
[TBL] [Abstract][Full Text] [Related]
20. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Yan X; Uronen RL; Huttunen HJ
Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]